Agenda

View the 2023 Brochure as a PDF
Full agenda details can be found on this page, but if you prefer to view the brochure as a PDF, click below.
- Jump to:
- At a Glance
- Day 1
- Day 2
- Print-friendly Format
Day 1 - Tuesday, May 23, 2023
8:30 |
CO-CHAIRS' OPENING REMARKSPharma & Biotech Patent Litigation Year in Review |
9:15 |
Developing Winning Patent Litigation Strategies for the Unified Patent Court |
10:15 |
Devising Tactics for Defending and Enforcing Patent Rights in Non-UPC Member Jurisdictions |
11:15 |
Morning Coffee Break |
11:45 |
UPC JUDICIAL ROUNDTABLECritical Considerations for Practitioners Entering Into the Unified Patent Court |
12:45 |
Networking Luncheon |
1:45 |
EU REGULATORY THINK TANKAnticipating the Impact of EU Regulatory Transformation on Pharmaceutical and Biotech Companies |
2:45 |
The Future of Plausibility: Managing the Implications of the EPO’s Decisions in BOA Referral G 2/21 |
3:45 |
Afternoon Break |
4:00 |
Let’s Talk SPCsExamining the Impact of Recent SPC Referral Cases and Addressing Key Questions on the Future of Unitary SPCs |
5:00 |
Assessing the Uptake of the SPC Manufacturing Waiver and Making Sense of Disputes Arising from Manufacturing Waiver Regulations |
5:30 |
Conference Adjourns for Cocktail Reception |
Day 2 - Wednesday, May 24, 2023
Day 1 - Tuesday, May 23, 2023
8:30 |
CO-CHAIRS' OPENING REMARKSPharma & Biotech Patent Litigation Year in Review![]() Dominic Adair ![]() Dr. Penny Gilbert ![]() Bert Oosting In the year since we last met, there have been numerous developments influencing the pharmaceutical and biotech patent litigation landscape in Europe. New pharmaceutical legislative reform and significant EBoA decisions are currently on the horizon, and of course – Germany’s ratification of the UPC Agreement has finally launched the countdown to the beginning of the Unitary Patent and Unified Patent Court on 1st June. In this opening session, our esteemed co-chairs will set the stage for the conference with a high-level exploration of the most significant developments impacting European life science patent practitioners in 2023. |
9:15 |
Developing Winning Patent Litigation Strategies for the Unified Patent Court![]() Gaëlle Bourout ![]() Philippe Campolini ![]() Mathilde Rauline
|
10:15 |
Devising Tactics for Defending and Enforcing Patent Rights in Non-UPC Member Jurisdictions![]() Thierry Calame ![]() Dr. Penny Gilbert ![]() Ida Gjessing ![]() Miquel Montañá
|
11:15 |
Morning Coffee Break |
11:45 |
UPC JUDICIAL ROUNDTABLECritical Considerations for Practitioners Entering Into the Unified Patent Court![]() Honorable Rian Kalden ![]() Honorable Margot Kokke Moderator:![]() Professor Willem Hoyng Tune in for an exclusive opportunity to hear from a panel of “in the know” UPC judges on the most important considerations for practitioners entering into the new court system. With the UPC set to open its doors on 1st June, this is a session you cannot afford to miss. Topics of discussion will include:
|
12:45 |
Networking Luncheon |
1:45 |
EU REGULATORY THINK TANKAnticipating the Impact of EU Regulatory Transformation on Pharmaceutical and Biotech Companies![]() Grant Castle ![]() Daan de Lange ![]() Sergio Napolitano LL.M. ![]() Ioana Ratescu
|
2:45 |
The Future of Plausibility: Managing the Implications of the EPO’s Decisions in BOA Referral G 2/21![]() Alessandra Attavino ![]() Koen Bijvank ![]() Dr. Sabrina Duschner ![]() Eleanor Root Moderator:![]() Bert Oosting
|
3:45 |
Afternoon Break |
4:00 |
Let’s Talk SPCsExamining the Impact of Recent SPC Referral Cases and Addressing Key Questions on the Future of Unitary SPCs![]() Karin Pramberger ![]() Oswin Ridderbusch SPC Case Law and Referrals
Unitary SPCS
|
5:00 |
Assessing the Uptake of the SPC Manufacturing Waiver and Making Sense of Disputes Arising from Manufacturing Waiver Regulations![]() Jiri Slavik
|
5:30 |
Conference Adjourns for Cocktail Reception |
Day 2 - Wednesday, May 24, 2023
8:30 |
Co-Chairs’ Welcome Back and Recap of Day 1 |
9:00 |
Transnational Tactics for Avoiding and Defending Contributory and Induced Infringement Claims![]() Dominic Adair ![]() Ruud van der Velden
|
9:45 |
The Emerging Battleground: Global Strategies for Biosimilars and Biologics Patent Litigation![]() Rob Rodrigues ![]() Daniel Lim Biologics and biosimilars are a rising patent battleground across the globe. As innovation and the biologics market grows, litigation is certain to keep pace with that growth. This panel will examine global strategies for biosimilars and innovator biologics patent litigation, with topics of discussion to include:
|
10:30 |
Morning Coffee Break |
11:00 |
Alternative Dispute Resolution: Preparing for the New UPC Patent Mediation and Arbitration Centre (PMAC)![]() Andrzej Gadkowski ![]() Philipp Groz ![]() Gordon Humphreys ![]() Benjamin May
|
11:45 |
Tracking Changes in Competition Law: Enforcement, Litigation, Settlements and Economic Considerations![]() Boris Andrejaš ![]() Maarten Meulenbelt Fireside Chat with the European Commission, DG Competition |
12:30 |
Networking Luncheon for Speakers and Delegates |
1:30 |
Successfully Claiming Antibody Patents in Europe and the U.S.: Incorporating Takeaways from the Latest Case Law Into Your Prosecution Strategy![]() Deborah Sterling ![]() Dr. Jörk Zwicker ![]() Peter Silverman Drafting antibody claims is a complex endeavor, and questions surrounding which claims are patentable in Europe and the U.S. remain increasingly difficult to navigate. This panel will offer solutions for successful patenting strategies and global commercialization. Points of discussion include:
|
2:15 |
Spotlight on Priority: Incorporating the Latest EPO and National Jurisprudence into Your Patent Enforcement Strategies![]() James Horgan ![]() Gregor König
|
3:00 |
Afternoon Break |
3:15 |
Spotlight on the U.S. and China: Examining the Influence and Implications of Legal and Regulatory Advancements Abroad![]() Robert V. Cerwinski ![]() Anthony Chen China
United States
|
4:15 |
Navigating the Patenting Challenges Of AI-Assisted Drug Discovery and Development![]() Ian Jones ![]() Pete Sadler While AI is having a tremendous impact on drug development, the lack of clarity in patent law for AI-driven innovations continues to create roadblocks to patenting inventions. This panel will discuss the latest ways that AI is being used in drug development, how patent registries and courts are interpreting the existing law in Europe and the U.S, and how companies are navigating patenting challenges surrounding:
|
5:00 |
Conference Concludes |